UBC acquires Examoto, LLC.

M2 EQUITYBITES-July 29, 2022-UBC acquires Examoto, LLC

(C)2022 M2 COMMUNICATIONS http://www.m2.com

UBC, a biopharmaceutical company, announced on Thursday that it has acquired Examoto, LLC, a US-based Risk Evaluation and Mitigation Strategy (REMS) company.

Financial terms of the deal were not revealed.

Patrick Lindsay, UBC's President and CEO, said, 'We are excited by the compelling opportunities this acquisition presents to expand the industry's leading one-stop-shop for full-service REMS programs. The combination...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT